Latest Singapore News

Lindian Resources confirms Kangankunde Rare Earths Project remains on track for first production in late 2026, with concurrent progress across construction, mining, and operational readiness. The company is expanding its operational footprint internationally and strengthening its team to support the transition from construction to production.

Percheron Therapeutics reduced its FY2026 loss to $4.79 million as it prepares to launch a pivotal phase II trial for its immuno-oncology drug HMBD-002, while managing a CEO transition and tightening cash reserves.

Viva Leisure posted a 12.2% revenue increase to $237.1 million and a 144.5% jump in net profit after tax for FY2026, declaring its first fully franked dividend and launching Meridium Global as a standalone payments and technology business.

Lark Distilling Co. Ltd grew net sales by 15% in FY26, driven by whisky and international expansion, but posted a $40 million loss after goodwill and inventory impairments.

Vita Life Sciences delivered a robust first half in 2026 with revenue up 6.1% to A$48.3 million and net profit after tax rising 14.9% to A$5.54 million. The company declared a higher interim dividend, reflecting improved margins and regional market momentum.

Scalare Partners offers 87 bonus options per 100 shares to eligible shareholders alongside piggyback options, aiming to mitigate dilution from upcoming convertible note conversions. Directors plan to exercise their options, with potential capital raised earmarked for working capital.

Avenira Ltd (ASX:AEV) is raising nearly $49 million through a heavily discounted three-for-two renounceable rights issue to finance the transition of its Wonarah Phosphate Project from development to production.

Steadfast Group's consortium reconfirms $6 per share cash offer, extending exclusivity to 21 August amid final due diligence.

Proteomics International has achieved a key patent acceptance in Australia for its PromarkerEndo blood test, reinforcing its intellectual property portfolio and commercialisation strategy in a major healthcare market.

De.mem Limited is poised for a record 2026, driven by 29 consecutive quarters of cash receipts growth, positive operating cashflow, and strategic expansion into the gold mining sector through Core Chemicals.

The Agency Group Australia (ASX:AU1) acknowledged ongoing discussions with Aura Group following a spike in share trading and an ASX inquiry. No binding deal is in place, and the company will update the market on material developments.

Mayfield Childcare has launched a $3 million entitlement offer, fully covered by major shareholder pre-commitments and partial underwriting, to bolster working capital and support its operational turnaround amid ongoing sector challenges.